Concepts (55)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Photochemotherapy | 2 | 2022 | 820 | 0.980 |
Why?
|
Acitretin | 1 | 2024 | 16 | 0.960 |
Why?
|
Keratolytic Agents | 1 | 2024 | 34 | 0.960 |
Why?
|
Bilirubin | 1 | 2024 | 437 | 0.820 |
Why?
|
Hutchinson's Melanotic Freckle | 1 | 2021 | 25 | 0.780 |
Why?
|
Erythema | 1 | 2021 | 262 | 0.700 |
Why?
|
Paget Disease, Extramammary | 1 | 2020 | 51 | 0.690 |
Why?
|
Receptors, Adrenergic, beta-2 | 4 | 2023 | 213 | 0.640 |
Why?
|
Psoriasis | 1 | 2024 | 938 | 0.530 |
Why?
|
Renal Dialysis | 1 | 2024 | 1786 | 0.480 |
Why?
|
Kidney Failure, Chronic | 1 | 2024 | 2457 | 0.390 |
Why?
|
Aminolevulinic Acid | 2 | 2022 | 142 | 0.360 |
Why?
|
Adrenergic beta-2 Receptor Agonists | 2 | 2019 | 107 | 0.300 |
Why?
|
Photosensitizing Agents | 2 | 2022 | 618 | 0.280 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2022 | 4023 | 0.280 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2022 | 9273 | 0.270 |
Why?
|
Arrestins | 1 | 2023 | 73 | 0.220 |
Why?
|
Skin Neoplasms | 1 | 2021 | 5797 | 0.200 |
Why?
|
Alkaline Phosphatase | 1 | 2024 | 865 | 0.190 |
Why?
|
Dihematoporphyrin Ether | 1 | 2020 | 33 | 0.180 |
Why?
|
Phthalic Anhydrides | 1 | 2019 | 3 | 0.170 |
Why?
|
Adrenergic beta-2 Receptor Antagonists | 1 | 2018 | 12 | 0.160 |
Why?
|
Allosteric Regulation | 4 | 2023 | 426 | 0.160 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2023 | 1240 | 0.150 |
Why?
|
Dipeptides | 1 | 2018 | 386 | 0.130 |
Why?
|
Microscopy, Confocal | 1 | 2021 | 1969 | 0.130 |
Why?
|
Small Molecule Libraries | 1 | 2018 | 724 | 0.100 |
Why?
|
Pilot Projects | 1 | 2022 | 8553 | 0.080 |
Why?
|
Allosteric Site | 2 | 2018 | 103 | 0.080 |
Why?
|
Signal Transduction | 2 | 2023 | 23342 | 0.050 |
Why?
|
Structure-Activity Relationship | 2 | 2018 | 3069 | 0.050 |
Why?
|
Humans | 7 | 2024 | 758406 | 0.050 |
Why?
|
Follow-Up Studies | 1 | 2022 | 39059 | 0.050 |
Why?
|
Iodocyanopindolol | 1 | 2018 | 10 | 0.040 |
Why?
|
Binding, Competitive | 1 | 2018 | 1141 | 0.030 |
Why?
|
GTP-Binding Protein alpha Subunits, Gs | 1 | 2018 | 195 | 0.030 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2023 | 1245 | 0.030 |
Why?
|
Retrospective Studies | 1 | 2024 | 80168 | 0.030 |
Why?
|
Gene Library | 1 | 2018 | 1059 | 0.030 |
Why?
|
Crystallography, X-Ray | 1 | 2019 | 1974 | 0.030 |
Why?
|
Iodine Radioisotopes | 1 | 2018 | 1032 | 0.030 |
Why?
|
Substrate Specificity | 1 | 2018 | 1792 | 0.030 |
Why?
|
Drug Synergism | 1 | 2018 | 1745 | 0.030 |
Why?
|
Molecular Structure | 1 | 2018 | 1866 | 0.030 |
Why?
|
GTP-Binding Proteins | 1 | 2018 | 950 | 0.030 |
Why?
|
Drug Design | 1 | 2018 | 1049 | 0.030 |
Why?
|
Phosphorylation | 1 | 2023 | 8297 | 0.030 |
Why?
|
Aged | 1 | 2024 | 168218 | 0.020 |
Why?
|
Middle Aged | 1 | 2024 | 219568 | 0.020 |
Why?
|
Adult | 1 | 2024 | 219935 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2018 | 4257 | 0.020 |
Why?
|
Male | 1 | 2024 | 358747 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2018 | 10748 | 0.020 |
Why?
|
Female | 1 | 2024 | 390323 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2018 | 16886 | 0.010 |
Why?
|
Concepts
(55)
Derived automatically from this person's publications.
Explore
_
Similar People
(59)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_